This month’s healthcare and pharmaceutical coverage highlights how political decisions and emerging technologies are redefining access to care and public confidence in the system. From Trump’s initiatives on drug pricing, fertility access, and AI-driven cancer research to growing scrutiny of AI’s role in medical advice, the discussions reflect a sector balancing innovation with regulation and […]
This month’s healthcare and pharmaceutical coverage underscores the growing tensions between medical innovation, public policy, and patient safety. From the FDA’s shift in COVID-19 vaccine guidance to controversial political backing of unproven autism research, and the rise of AI-powered diagnostic tools such as smart stethoscopes, the industry is navigating a rapidly changing environment. These developments […]
